Sunitinib
Showing 26 - 50 of 729
Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)
Not yet recruiting
- Gastrointestinal Stromal Tumors
- Rivoceranib Mesylate, Paclitaxel
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023
Renal Cell Carcinoma, Metastatic Trial in Worldwide (Intuvax (INN: ilixadencel), Sunitinib)
Completed
- Renal Cell Carcinoma, Metastatic
- Intuvax (INN: ilixadencel)
- Sunitinib
-
Chicago, Illinois
- +27 more
Jul 23, 2022
Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)
Active, not recruiting
- Paraganglioma
- Pheochromocytoma
- Sunitinib
-
Calgary, Alberta, Canada
- +3 more
Nov 29, 2021
Renal Cell Carcinoma Metastatic Trial in Hershey (Abemaciclib, Sunitinib)
Active, not recruiting
- Renal Cell Carcinoma Metastatic
- Abemaciclib
- Sunitinib
-
Hershey, PennsylvaniaPenn State Cancer Institute
Jan 5, 2022
Kidney Tumors, Metastatic Renal Cell Cancer Trial in Besancon (Sunitinib)
Active, not recruiting
- Kidney Neoplasms
- Metastatic Renal Cell Cancer
- Sunitinib
-
Besancon, Franche-Comté, FranceCHU Besancon
Nov 17, 2021
CR With Sunitinib Treatment In mRCC Patients
Completed
- Complete Remission in Renal Cell Carcinoma
- sunitinib
-
Marseille, Cedex 5, France
- +13 more
Feb 14, 2022
Renal Cell Carcinoma Trial (Sunitinib)
Not yet recruiting
- Renal Cell Carcinoma
- Sunitinib
- (no location specified)
Sep 11, 2023
Non GIST Sarcomas Trial in France (sunitinib)
Completed
- Non GIST Sarcomas
- sunitinib
-
Bordeaux, France
- +5 more
Jan 3, 2022
Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)
Recruiting
- Gastrointestinal Stromal Tumors
- Pimitespib
- +2 more
-
Tokyo, JapanA site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022
Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab
Recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
- +7 more
-
Bologna, Italy
- +12 more
Nov 10, 2021
Gastrointestinal Stromal Tumors Trial in Changsha (Apatinib Mesylate, Sunitinib, Imatinib dosage, Dasatinib, Reveratinib)
Recruiting
- Gastrointestinal Stromal Tumors
- Apatinib Mesylate
- Sunitinib, Imatinib dosage, Dasatinib, Reveratinib
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
Mar 1, 2023
Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)
Completed
- Diabetic Macular Edema
- Retina Vein Occlusion
-
Phoenix, Arizona
- +5 more
Nov 18, 2021
Small Cell Lung Cancer Trial in United States (irinotecan, Carboplatin, sunitinib)
Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,
Completed
- Renal Cell Carcinoma
- Clear-cell Metastatic Renal Cell Carcinoma
- Nivolumab
- +3 more
-
Duarte, California
- +13 more
Nov 30, 2021
Lung Neuroendocrine Tumor, GEP Neuroendocrine Tumor Trial in Naples (Cabozantinib and Temozolomide)
Recruiting
- Lung Neuroendocrine Neoplasm
- GEP Neuroendocrine Tumor
- Cabozantinib and Temozolomide
-
Naples, Campania, ItalyNational Cancer Institute of Naples
Oct 12, 2021
Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)
Recruiting
- Type B3 Thymoma
- Thymic Carcinoma
- Sunitinib
-
Milan, ItalyNational Cancer Institute
Jun 8, 2021
Metastatic Renal Cell Carcinoma Trial in Paris (Nephrectomy, Sunitinib alone)
Completed
- Metastatic Renal Cell Carcinoma
- Nephrectomy
- Sunitinib alone
-
Paris, FranceHopital Necker
Apr 13, 2021
Carcinoma, Renal Cell Trial in China, Korea, Republic of, Taiwan (Pazopanib, Sunitinib)
Completed
- Carcinoma, Renal Cell
- Pazopanib
- Sunitinib
-
Guangzhou, Guangdong, China
- +20 more
Dec 6, 2021
Avapritinib in Chinese Gastrointestinal Stromal Tumor in Real
Recruiting
- Gastrointestinal Stromal Tumors
- Avapritinib
- Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 14, 2022
Kidney Cancer Trial in Boston, Houston, Salt Lake City (Everolimus, Sunitinib)
Kidney Cancer Trial in New Brunswick (therapeutic allogeneic lymphocytes, sunitinib malate)
Terminated
- Kidney Cancer
- therapeutic allogeneic lymphocytes
- sunitinib malate
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 23, 2021
Glioblastoma Multiforme, Glioblastoma, Adult, Glioblastoma Trial in Amsterdam, Groningen, Nijmegen (Sunitinib, Lomustine)
Recruiting
- Glioblastoma Multiforme
- +4 more
- Sunitinib
- Lomustine
-
Amsterdam, Netherlands
- +2 more
Apr 14, 2021
Advanced Rare Tumours Trial in Canada (Sunitinib, Temsirolimus)
Active, not recruiting
- Advanced Rare Tumours
- Sunitinib
- Temsirolimus
-
Calgary, Alberta, Canada
- +16 more
Mar 17, 2022
Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)
Active, not recruiting
- Carcinoma
- +7 more
- Savolitinib
- Sunitinib
-
La Jolla, California
- +58 more
Jan 13, 2023